Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study

Authors
Publication date
1 January 2008
Publisher
Springer-Verlag
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 03/05/2017

      Crossref

      redirect
      Last time updated on 01/04/2019

      Springer - Publisher Connector

      redirect
      Last time updated on 05/06/2019

      Crossref

      redirect
      Last time updated on 27/12/2021